PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2005 June; 6(2): E323–E328.
Published online 2005 October 6. doi:  10.1208/pt060242
PMCID: PMC2750545

Development of a dialysis in vitro release method for biodegradable microspheres

Abstract

The purpose of this research was to develop a simple and convenient in vitro release method for biodegradable microspheres using a commercially available dialyzer. A 25 KD MWCO Float-a-Lyzer was used to evaluate peptide diffusion at 37°C and 55°C in different buffers and assess the effect of peptide concentration. In vitro release of Leuprolide from PLGA microspheres, having a 1-month duration of action, was assessed using the dialyzer and compared with the commonly used “sample and separate” method with and without agitation. Peptide diffusion through the dialysis membrane was rapid at 37°C and 55°C in all buffers and was independent of peptide concentration. There was no detectable binding to the membrane under the conditions of the study. In vitro release of Leuprolide from PLGA microspheres was tri-phasic and was complete in 28 days with the dialysis technique. With the sample and separate technique, linear release profiles were obtained with complete release occurring under conditions of agitation. Diffusion through the dialysis membrane was sufficiently rapid to qualify the Float-a-Lyzer for an in vitro release system for microparticulate dosage forms. Membrane characteristics render it useful to study drug release under real-time and accelerated conditions.

KeyWords: biodegradable microspheres, in vitro release methods, dialysis

Full Text

The Full Text of this article is available as a PDF (206K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28:5–24. doi: 10.1016/S0169-409X(97)00048-3. [PubMed] [Cross Ref]
2. Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90:261–280. doi: 10.1016/S0168-3659(03)00194-9. [PubMed] [Cross Ref]
3. Zhou S, Liao X, Li X, Deng X, Li H. Poly-D,L-lactideco-poly(ethylene glycol) microspheres as potential vaccine delivery systems. J Control Release. 2003;86:195–205. doi: 10.1016/S0168-3659(02)00423-6. [PubMed] [Cross Ref]
4. Wu L, Ding J. In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials. 2004;25:5821–5830. doi: 10.1016/j.biomaterials.2004.01.038. [PubMed] [Cross Ref]
5. Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials. 2000;21:2335–2346. doi: 10.1016/S0142-9612(00)00101-0. [PubMed] [Cross Ref]
6. Hickey T, Kreutzer D, Burgess DJ, Moussy F. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials. 2002;23:1649–1656. doi: 10.1016/S0142-9612(01)00291-5. [PubMed] [Cross Ref]
7. Burgess DJ, Hickey AJ. Microsphere technology and applications. In: Swarbrick J, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology. New York, NY: Marcel Dekker; 1994. pp. 1–29.
8. Burgess DJ, Hussain AS, Ingallinera TS, Chen ML. Assuring quality and performance of sustained and controlled release parenterals: workshop report. AAPS Pharm Sci. 2002;4(2):E7–E7. doi: 10.1208/ps040207. [PMC free article] [PubMed] [Cross Ref]
9. Schaefer MJ, Singh J. Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres. Biomaterials. 2002;23:3465–3471. doi: 10.1016/S0142-9612(02)00053-4. [PubMed] [Cross Ref]
10. Ruan G, Feng S-S, Li Q-T. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. J Control Release. 2002;84:151–160. doi: 10.1016/S0168-3659(02)00292-4. [PubMed] [Cross Ref]
11. Ruan G, Feng S-S. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials. 2003;24:5037–5044. doi: 10.1016/S0142-9612(03)00419-8. [PubMed] [Cross Ref]
12. Diwan M, Park TG. Stabilization of recombinant interferon-α by pegylation for encapsulation in PLGA microspheres. Int J Pharm. 2003;252:111–122. doi: 10.1016/S0378-5173(02)00636-1. [PubMed] [Cross Ref]
13. Liu FI, Kuo JH, Sung KC, Hu OY. Biodegradable polymeric microspheres for nalbuphine prodrug controlled delivery: in vitro characterization and in vivo pharmacokinetic studies. Int J Pharm. 2003;257:23–31. doi: 10.1016/S0378-5173(03)00110-8. [PubMed] [Cross Ref]
14. Poulain N, Dez I, Perrio C, Lasne MC, Prud’homme MP, Nakache E. Microspheres based on inulin for the controlled release of serine protease inhibitors: preparation, characterization and in vitro release. J Control Release. 2003;92:27–38. doi: 10.1016/S0168-3659(03)00251-7. [PubMed] [Cross Ref]
15. Larsen DH, Fredholt K, Larsen C. Assessment of rate of drug release from oil vehicle using a rotating dialysis cell. Eur J Pharm Sci. 2000;11:223–229. doi: 10.1016/S0928-0987(00)00105-6. [PubMed] [Cross Ref]
16. Park TG, Lu W, Crotts G. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D,L-lactic acid-co-glycolic acid) microspheres. J Control Release. 1995;33:211–222. doi: 10.1016/0168-3659(94)00084-8. [Cross Ref]
17. Berthold A, Cremer K, Kreuter J. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J Control Release. 1996;39:17–25. doi: 10.1016/0168-3659(95)00129-8. [Cross Ref]
18. Diaz RV, Llabres M, Evora C. One-month sustained release microspheres of 125I-bovine calcitonin: In vitro-in vivo studies. J Control Release. 1999;59:55–62. doi: 10.1016/S0168-3659(98)00179-5. [PubMed] [Cross Ref]
19. Woo BH, Kostanski JW, Gebrekidan S, Dani BA, Thanoo BC, DeLuca PP. Preparation, characterization and in vivo evaluation of 120-day poly(-lactide) leuprolide microspheres. J Control Release. 2001;75:307–315. doi: 10.1016/S0168-3659(01)00403-5. [PubMed] [Cross Ref]
20. Kostanski JW, DeLuca PP. A novel in vitro release technique for peptide-containing biodegradable microspheres. AAPS Pharm Sci Tech. 2000;1:E4–E4. doi: 10.1208/pt010104. [PMC free article] [PubMed] [Cross Ref]
21. Shameem M, Heeyong L, DeLuca PP. A short-term (accelerated release) approach to evaluate peptide release from PLGA depot formulations. AAPS Pharm Sci. 1999;1:E7–E7. doi: 10.1208/ps010307. [PMC free article] [PubMed] [Cross Ref]
22. Burgess DJ, Hussain AS, Ingallinera TS, Chen ML. Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP. Pharm Res. 2002;19:1761–1768. doi: 10.1023/A:1020730102176. [PubMed] [Cross Ref]
23. Sturesson C, Artursson P, Ghaderi R, et al. Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres. J Control Release. 1999;59:377–389. doi: 10.1016/S0168-3659(99)00014-0. [PubMed] [Cross Ref]
24. Özbas-Turan S, Akbuga J, Aral C. Controlled release of interleukin-2 from chitosan microspheres. J Pharm Sci. 2002;91:1245–1251. doi: 10.1002/jps.10122. [PubMed] [Cross Ref]
25. Mi FL, Shyu SS, Lin YM, Wu YB, Peng CK, Tsai YH. Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein. Biomaterials. 2003;24:5023–5036. doi: 10.1016/S0142-9612(03)00413-7. [PubMed] [Cross Ref]
26. Constantino HR, Johnson OL, Zale SE. Relationship between encapsulated drug particle size and initial release of recombinant human growth hormone from biodegradable microspheres. J Pharm Sci. 2004;93:2624–2634. doi: 10.1002/jps.20078. [PubMed] [Cross Ref]
27. Dasaratha Dhanaraju M, Vema K, Jayakumar R, Vamsadhara C. Preparation and characterization of injectable microspheres of contraceptive hormones. Int J Pharm. 2003;268:23–29. doi: 10.1016/j.ijpharm.2003.08.011. [PubMed] [Cross Ref]
28. Shah VP, Gurbarg M, Noory A, Dighe S, Skelly JP. Influence of higher rates of agitation on release patterns of immediate-release drug products. J Pharm Sci. 1992;81:500–503. doi: 10.1002/jps.2600810604. [PubMed] [Cross Ref]
29. Kamba M, Seta Y, Takeda N, et al. Measurement of agitation force in dissolution test and mechanical destructive force in disintegration test. Int J Pharm. 2003;250:99–109. doi: 10.1016/S0378-5173(02)00535-5. [PubMed] [Cross Ref]
30. Costa P, Lobo JMS. Influence of dissolution medium agitation on release profiles of sustained-release tablets. Drug Dev Ind Pharm. 2001;27:811–817. doi: 10.1081/DDC-100107244. [PubMed] [Cross Ref]
31. Shenderova A, Burke TG, Schwendeman SP. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes comptothecins. Pharm Res. 1999;16(2):241–248. doi: 10.1023/A:1018876308346. [PubMed] [Cross Ref]
32. Mader K, Bittner B, Li Y, Wohlauf W, Kissel T. Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophilic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene) B blocks. Pharm Res. 1998;15:787–793. doi: 10.1023/A:1011939607573. [PubMed] [Cross Ref]
33. Zhu G, Mallery SR, Schwendeman SP. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide) Nat Biotechnol. 2000;18:52–57. doi: 10.1038/71916. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists